ANI Pharmaceuticals
ANIP
#5413
Rank
$1.53 B
Marketcap
$67.41
Share price
-3.17%
Change (1 day)
-24.20%
Change (1 year)

P/S ratio for ANI Pharmaceuticals (ANIP)

P/S ratio as of November 2026 (TTM): 1.57

According to ANI Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.57. At the end of 2023 the company had a P/S ratio of 2.31.

P/S ratio history for ANI Pharmaceuticals from 2001 to 2023

PS ratio at the end of each year

Year P/S ratio Change
20232.314.25%
20222.22-37.55%
20213.55106.33%
20201.72-52.33%
20193.6136.37%
20182.65-37.62%
20174.25-22.25%
20165.46-19.72%
20156.80-40.75%
201411.546.48%
20137.84-40.11%
201213.1-89.69%
2011127134.16%
201054.2-12.34%
200961.8748.33%
20087.29-96.5%
20072084549.39%
20064.48-98.36%
2005274-79.87%
2004> 10004366.23%
200330.5383.09%
20026.31-78.89%
200129.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
5.35 241.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.63 67.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
0.2470-84.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
3.28 109.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
1.31-16.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
> 1000 948,063.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.87 83.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
15.3 874.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
0.0238-98.48%๐Ÿ‡บ๐Ÿ‡ธ USA